WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. This comprehensive, next-generation sequencing evaluation investigates approximately 20,000 genes for variations associated with ge
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:32):
Before we jump in, would each of you share a little bit about your background and yourselves?
(01:18):
Dr. Marcou. could you provide us with an overview of what the WESDX test is?
(01:50):
Marissa, would you help explain why this test is important?
(03:10):
In your experience who would benefit from WESDX,
(05:12):
How does a provider order A WES DX and secondarily what type of samples are accepted?
(06:24):
What types of variants are detected by the test?
(07:47):
There are a lot of exome tests available. What are some other unique features that set WESDX apart?
(09:52):
Last question, could you summarize the benefits of doing WESDX at Mayo?